Elliot Norry, Chief Medical Officer at Adaptimmune Therapeutics PLC (ADAP), sold 11,808 shares at $0.84 ($10K) on 2024-01-11, disclosed to the SEC on 2024-01-12.
Seasonal sale ($10k) by Chief Medical Officer — this insider has traded ADAP in January in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.84 | 4,009 | $3K | 33.7% |
| 2 | $0.85 | 7,799 | $7K | 66.3% |
| Total | $0.85 avg | 11,808 | $10K | 100% |
| Filing → |
| ADAP | SELL | 2024-01-17 | $14K | — | Filing → |
| ADAP | SELL | 2023-01-17 | $4K | — | Filing → |
| ADAP | SELL | 2023-01-12 | $19K | — | Filing → |